CHSE Odisha Elective Biotechnology flashcards
CHSE Odisha Elective Biotechnology · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Biotechnology
- Any technological application that uses biological systems, living organisms or their derivatives to make or modify products or processes for a specific use, spanning medicine, agriculture, industry and environment.
- Department of Biotechnology
- Indian government agency established in 1986 under the Ministry of Science and Technology to promote research, infrastructure and regulation of biotechnology, including the RCGM.
- Fluid mosaic model
- Model proposed by Singer and Nicolson in 1972 describing the plasma membrane as a phospholipid bilayer with proteins embedded or attached, able to move laterally.
- Chemiosmotic theory
- Peter Mitchell's explanation that a proton gradient across the inner mitochondrial membrane drives ATP synthase to produce ATP during oxidative phosphorylation.
- Generation time
- The time a bacterial population takes to double during exponential growth; calculated as g = t/n where n is the number of doublings in time t.
- Gram staining
- Differential staining using crystal violet, iodine, alcohol and safranin; Gram-positive cells retain the purple dye, Gram-negative cells appear pink after counterstaining.
- Semiconservative replication
- Each new DNA molecule retains one parental strand and one newly synthesised strand; demonstrated by the Meselson-Stahl density gradient experiment.
- Okazaki fragments
- Short DNA pieces synthesised discontinuously on the lagging strand in the direction opposite to fork movement, later joined by DNA ligase.
- Restriction endonuclease
- Enzyme that cuts DNA at a specific recognition sequence; Type II enzymes such as EcoRI cut palindromic sites and are widely used in cloning.
- Blue-white screening
- Selection method where insert-containing plasmids disrupt lacZ, giving white colonies on X-gal plates, while non-recombinant plasmids produce blue colonies.
- Polymerase chain reaction
- In vitro amplification of DNA using repeated cycles of denaturation, primer annealing and extension by a thermostable polymerase, doubling the target each cycle.
- Murashige and Skoog medium
- Widely used plant tissue culture medium containing macroelements, microelements, vitamins, sucrose and growth regulators, solidified with agar at pH 5.7-5.8.
- Totipotency
- The capacity of a single plant cell to regenerate into a complete plant under suitable culture conditions, the basis of micropropagation.
- Agrobacterium tumefaciens
- Soil bacterium that transfers T-DNA from its Ti plasmid into plant cells, exploited as a natural vector for plant genetic engineering.
- Hybridoma technology
- Fusion of an antibody-producing B cell with an immortal myeloma cell to produce hybrid cells that secrete monoclonal antibodies indefinitely in culture.
- HeLa cell line
- First continuous human cell line, derived from cervical carcinoma in 1951, widely used in research because it grows indefinitely in culture.
- Stirred tank fermenter
- Bioreactor with an impeller and baffles for mixing, sparging air for oxygen transfer, used for submerged fermentation of antibiotics, enzymes and metabolites.
- kLa
- Volumetric oxygen transfer coefficient describing the rate of oxygen transfer from gas to liquid in a fermenter; a key scale-up parameter.
- Downstream processing
- Recovery and purification of a fermentation product, involving cell separation, disruption, concentration, chromatography and formulation steps.
- BOD5
- Biochemical oxygen demand measured over five days at 20 degrees Celsius, indicating biodegradable organic load in water and wastewater.
- Phytoremediation
- Use of plants to remove, stabilise or degrade contaminants in soil and water, including phytoextraction, rhizofiltration and phytovolatilisation.
- Activated sludge process
- Aerobic wastewater treatment where microorganisms in aerated mixed liquor degrade organic matter, followed by settlement in a clarifier and sludge recycling.
- Recombinant insulin
- Human insulin produced by genetically engineered E. coli or yeast carrying the insulin gene; approved in 1982 as the first rDNA pharmaceutical.
- Monoclonal antibody
- Identical antibody molecules from a single clone, binding one specific epitope; used in cancer therapy, diagnostics and autoimmune disease treatment.
- Therapeutic index
- Ratio of the toxic dose to the effective dose (TD50/ED50); a larger value indicates a wider margin of drug safety.
- Herd immunity
- Indirect protection of unvaccinated individuals when a sufficient proportion of the population is immune; threshold equals 1 minus 1/R0.
- MHC class I
- Cell surface molecule on nearly all nucleated cells that presents endogenous peptides to CD8-positive cytotoxic T lymphocytes.
- Immunoglobulin M
- Pentameric antibody produced early in a primary immune response; strong complement activator and marker of recent infection.
- GEAC
- Genetic Engineering Appraisal Committee under the Ministry of Environment, Forest and Climate Change, which approves environmental release and field trials of genetically modified organisms in India.
- Cartagena Protocol
- International agreement on biosafety governing transboundary movement of living modified organisms, ensuring informed consent and risk assessment.
- Patentability criteria
- An invention must show novelty, an inventive step and industrial application; in India, plants, animals and essentially biological processes are excluded from patenting.
- Biosafety level
- Containment classification from BSL-1 to BSL-4 based on pathogen risk, specifying laboratory design, equipment, PPE and waste treatment practices.